Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Pfizer (NY: PFE )

26.72 -0.32 (-1.18%)
Official Closing Price Updated: 7:00 PM EST, Nov 8, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 55,951,403
Open 27.11
Bid (Size) 26.74 (1)
Ask (Size) 26.75 (10)
Prev. Close 27.04
Today's Range 26.71 - 27.15
52wk Range 25.20 - 31.54
Shares Outstanding 5,606,688,356
Dividend Yield 6.14%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
3 Spectacular High-Yield Dividend Stocks to Buy in November
High yields aren't a warning indicator with these three stocks. 
Via The Motley Fool
2 Magnificent S&P 500 Dividend Stocks Down Year to Date to Buy and Hold Forever
More than a few companies that did well in the past are out of favor with investors. And that could spell opportunity. 
Via The Motley Fool
Topics Stocks
Exposures US Equities

Performance

YTD
-10.12%
-10.12%
1 Month
-8.37%
-8.37%
3 Month
-6.08%
-6.08%
6 Month
-6.05%
-6.05%
1 Year
-7.80%
-7.80%

More News

Read More
Moderna's Q3 Earnings Beat Overshadowed By Vaccine Demand Slowdown And Market Share Concerns, Analysts Warn
Via Benzinga
Topics Earnings
Exposures COVID-19 Financial
Trump's Potential 'Health Czar' Robert F. Kennedy Jr. Rattles Vaccine Stocks: 'Shoot First Reaction'
Via Benzinga
Topics Government
Exposures Political
2 Healthcare Dividend Stocks That Are Screaming Buys in November
Via The Motley Fool
Peering Into Pfizer's Recent Short Interest
Via Benzinga
3 Reasons Pfizer Looks Like a No-Brainer Buy Right Now
Via The Motley Fool
Moderna Posts A Surprise Profit As Sales Wallop Views. But Will RSV Be Its Undoing?
Via Investor's Business Daily
Trump Has Asked Me To Do 3 Things, Says Robert Kennedy Jr.
Via Benzinga
Topics Government
Exposures Political
2 Magnificent Stocks to Buy That Are Near 52-Week Lows
Via The Motley Fool
How this award-winning TV host is setting the stage to help protect her health
Via Brandpoint
1 Green Flag That's Also a Red Flag for Pfizer Stock
Via The Motley Fool
Volatility Hits Large Cap Biopharma: Active Rebalancing May Be Required
Via Talk Markets
Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference
From Pfizer Inc.
Via Business Wire
Is Pfizer Stock a Bargain for Long-Term Investors?
Via The Motley Fool
2 Sensational Growth Stocks to Buy at a Discount
Via The Motley Fool
This Beaten-Down Stock Just Gave Investors More Good News: Is it a Buy?
Via The Motley Fool
3 Potential Catalysts That Could Lift Pfizer Stock Before 2025
Via The Motley Fool
Stock Market Retreats Before Election Day; Microsoft, Apple, Amazon, Google, Meta In Focus: Weekly Review
Via Investor's Business Daily
3 Reasons Relying on Social Security Alone Could be a Risk. And 3 Stocks to Invest in Today.
Via The Motley Fool
Cancer-Focused ESSA Pharma Ends Prostate Cancer Trial Due to Insufficient Efficacy From Combination Therapy
Via Benzinga
Stocks Going Ex Dividend In November 2024
Via Talk Markets
AWKO Files Lawsuit on Behalf of Sickle Cell Patient Against Pfizer’s Subsidiary
Via Law Firm Newswire
Topics Lawsuit
Exposures Financial Legal
3 Factors That Make Pfizer's Ultra-High-Yield Dividend Safer Than You Might Think
Via The Motley Fool
Amgen 'Laser-Focused' On Its Weight-Loss Shot As New Rival Pfizer Follows, Says CFO
Via Investor's Business Daily
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.